Company Profile
Public information reviewed
- Public sources
- 1 reviewed
- Published leadership records
- 23
- Last reviewed
- Sep 14, 2026
Agent View
Machine representations
Inspect the same governed public record as Markdown, structured data, or a retrieval endpoint.
Markdown
https://registry.alpha.ac/companies/novavax-inc.mdNOVAVAX INC
Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.
Record
| Field | Value |
|---|---|
| Representation | alpha-profile-markdown-v3 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1 |
| Canonical entity | alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/novavax-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 26 |
| Claims under review | 1 |
| Evidence records | 4 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-09-14T14:36:15.725755+00:00 |
| Last reviewed | 2026-09-14T14:36:15.725755+00:00 |
Identity
- Legal name: NOVAVAX INC
- Display name: NOVAVAX INC
Leadership
- David Mott: Chairman of the Board. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:2.
- Alderya Therapeutics: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:3.
- Amicus Therapeutics: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:3.
- AuraVax Therapeutics: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:3.
- Brii Biosciences: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:3.
- Charles W. Newton: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:3.
- Gregg H. Alton: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:2.
- John C. Jacobs: President and Chief Executive Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:2.
- John W. Shiver: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:2.
- Margaret G. McGlynn: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:2.
- Maryland Life Sciences Advisory: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:3.
- Opus Genetics: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:3.
- Rachel K. King: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:2.
- Richard H. Douglas: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:2.
- Richard J. Rodgers: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:2.
- Elaine O'Hara: Executive Vice President, Chief Strategy Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:2.
- James P. Kelly: Executive Vice President, Chief Financial Officer and Treasurer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:2.
- Jeffrey D. Kelly: Named Executive Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:4.
- John C. Jacobs: President and Chief Executive Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:2.
- John Trizzino: Named Executive Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:4.
- Mark J. Casey: Executive Vice President, Chief Legal Officer and Corporate Secretary. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:2.
- Michael Casey: Executive Vice President, Chief Legal Officer and Corporate Secretary. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:4.
- Ruxandra Draghia-Akli: Named Executive Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:4.
Roles
- PUBLISHED
Governance
- NOT_ASSERTED
Board committees
- PUBLISHED
Financials
- NOT_ASSERTED
Workforce
- NOT_ASSERTED
Market and index context
- PUBLISHED
Legal Name
- NOVAVAX INC. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:1.
Headquarters
- US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review.
Entity Status
- Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:1.
Published Fact
- US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:1.
Coverage states
| Field | Value |
|---|---|
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |
Public sources
- alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:1: Alpha canonical company public projection.
- alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:2: SEC DEF 14A 0001628280-26-027328.
- alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:3: DEF 14A nvax-20260427.htm.
- alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:4: NVAX DEF 14A executive officers.
Rights
| Field | Value |
|---|---|
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |
Limitations
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
Alternate representations
- Canonical profile
- Public Markdown
- Public JSON
- JSON-LD
- MCP resource:
alpha://companies/novavax-incat https://mcp.alpha.ac/mcp